A comparison of hypothermia and methyl isobutyl amiloride as cerebroprotectants against ischemia

John D. Davis, James J. Vornov, Rafael J Tamargo

Research output: Contribution to journalArticle

Abstract

Cerebral ischemic reperfusion injury may occur due to rapid realkalinization of neurons. We have previously shown in vitro that blockade of Na+/H+ antiporters by amiloride analogs slows realkalinization and reduces rat hippocampal cell death. We compare here the in vivo efficacy of methyl isobutyl amiloride (MIA), an amiloride analog shown to cross the blood-brain barrier, to that of hypothermia in reducing infarct volume using the rat thread middle cerebral artery (MCA) occlusion model. Thirty-nine male Sprague-Dawley rats were anesthetized with enflurane and equally divided into three groups by treatment: MIA, hypothermia, and control. Ischemia was induced using MCA thread occlusion and maintained for 2 hours. After confirmation of contralateral hemiparesis, the rats were reanesthetized, injected with MIA or carrier, and the suture withdrawn. Standard physiological parameters were monitored in all groups. Animals were killed the following day. Coronally sliced sections were stained in 1% tetrazolium red. Infarct volume was calculated as a percentage of the contralateral hemisphere volume to eliminate the effect of ipsilateral edema. Infarct volume for controls was 44.2 ± 6.4% (mean ± standard error of mean), for MIA group was 53.5 ± 7.5% (Bonferroni-Dunn, p = 0.31), and for hypothermia group was significantly lower at 6.9 ± 4.7% (p = 0.003). Average temperature at onset of ischemia for MIA and control groups was 37.4°C but for hypothermia group it was 31.4°. In addition, the hypothermic group differed physiologically from the other groups by a lower pH secondary to hypoventilation and hypercarbia. We conclude that MIA as administered here is not protective in temporary cerebral ischemia. Hypothermia, however, is confirmed to be an effective protectant in this model.

Original languageEnglish (US)
JournalJournal of Neurosurgery
Volume88
Issue number1
StatePublished - 1998
Externally publishedYes

Fingerprint

Amiloride
Hypothermia
Ischemia
Middle Cerebral Artery Infarction
Hypoventilation
Enflurane
Sodium-Hydrogen Antiporter
Hypercapnia
Paresis
Reperfusion Injury
Brain Ischemia
Blood-Brain Barrier
Sutures
Sprague Dawley Rats
Edema
Cell Death
Neurons
Control Groups
Temperature

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

A comparison of hypothermia and methyl isobutyl amiloride as cerebroprotectants against ischemia. / Davis, John D.; Vornov, James J.; Tamargo, Rafael J.

In: Journal of Neurosurgery, Vol. 88, No. 1, 1998.

Research output: Contribution to journalArticle

@article{f95e7ecdf228405a9651d5dffc50ccfe,
title = "A comparison of hypothermia and methyl isobutyl amiloride as cerebroprotectants against ischemia",
abstract = "Cerebral ischemic reperfusion injury may occur due to rapid realkalinization of neurons. We have previously shown in vitro that blockade of Na+/H+ antiporters by amiloride analogs slows realkalinization and reduces rat hippocampal cell death. We compare here the in vivo efficacy of methyl isobutyl amiloride (MIA), an amiloride analog shown to cross the blood-brain barrier, to that of hypothermia in reducing infarct volume using the rat thread middle cerebral artery (MCA) occlusion model. Thirty-nine male Sprague-Dawley rats were anesthetized with enflurane and equally divided into three groups by treatment: MIA, hypothermia, and control. Ischemia was induced using MCA thread occlusion and maintained for 2 hours. After confirmation of contralateral hemiparesis, the rats were reanesthetized, injected with MIA or carrier, and the suture withdrawn. Standard physiological parameters were monitored in all groups. Animals were killed the following day. Coronally sliced sections were stained in 1{\%} tetrazolium red. Infarct volume was calculated as a percentage of the contralateral hemisphere volume to eliminate the effect of ipsilateral edema. Infarct volume for controls was 44.2 ± 6.4{\%} (mean ± standard error of mean), for MIA group was 53.5 ± 7.5{\%} (Bonferroni-Dunn, p = 0.31), and for hypothermia group was significantly lower at 6.9 ± 4.7{\%} (p = 0.003). Average temperature at onset of ischemia for MIA and control groups was 37.4°C but for hypothermia group it was 31.4°. In addition, the hypothermic group differed physiologically from the other groups by a lower pH secondary to hypoventilation and hypercarbia. We conclude that MIA as administered here is not protective in temporary cerebral ischemia. Hypothermia, however, is confirmed to be an effective protectant in this model.",
author = "Davis, {John D.} and Vornov, {James J.} and Tamargo, {Rafael J}",
year = "1998",
language = "English (US)",
volume = "88",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "1",

}

TY - JOUR

T1 - A comparison of hypothermia and methyl isobutyl amiloride as cerebroprotectants against ischemia

AU - Davis, John D.

AU - Vornov, James J.

AU - Tamargo, Rafael J

PY - 1998

Y1 - 1998

N2 - Cerebral ischemic reperfusion injury may occur due to rapid realkalinization of neurons. We have previously shown in vitro that blockade of Na+/H+ antiporters by amiloride analogs slows realkalinization and reduces rat hippocampal cell death. We compare here the in vivo efficacy of methyl isobutyl amiloride (MIA), an amiloride analog shown to cross the blood-brain barrier, to that of hypothermia in reducing infarct volume using the rat thread middle cerebral artery (MCA) occlusion model. Thirty-nine male Sprague-Dawley rats were anesthetized with enflurane and equally divided into three groups by treatment: MIA, hypothermia, and control. Ischemia was induced using MCA thread occlusion and maintained for 2 hours. After confirmation of contralateral hemiparesis, the rats were reanesthetized, injected with MIA or carrier, and the suture withdrawn. Standard physiological parameters were monitored in all groups. Animals were killed the following day. Coronally sliced sections were stained in 1% tetrazolium red. Infarct volume was calculated as a percentage of the contralateral hemisphere volume to eliminate the effect of ipsilateral edema. Infarct volume for controls was 44.2 ± 6.4% (mean ± standard error of mean), for MIA group was 53.5 ± 7.5% (Bonferroni-Dunn, p = 0.31), and for hypothermia group was significantly lower at 6.9 ± 4.7% (p = 0.003). Average temperature at onset of ischemia for MIA and control groups was 37.4°C but for hypothermia group it was 31.4°. In addition, the hypothermic group differed physiologically from the other groups by a lower pH secondary to hypoventilation and hypercarbia. We conclude that MIA as administered here is not protective in temporary cerebral ischemia. Hypothermia, however, is confirmed to be an effective protectant in this model.

AB - Cerebral ischemic reperfusion injury may occur due to rapid realkalinization of neurons. We have previously shown in vitro that blockade of Na+/H+ antiporters by amiloride analogs slows realkalinization and reduces rat hippocampal cell death. We compare here the in vivo efficacy of methyl isobutyl amiloride (MIA), an amiloride analog shown to cross the blood-brain barrier, to that of hypothermia in reducing infarct volume using the rat thread middle cerebral artery (MCA) occlusion model. Thirty-nine male Sprague-Dawley rats were anesthetized with enflurane and equally divided into three groups by treatment: MIA, hypothermia, and control. Ischemia was induced using MCA thread occlusion and maintained for 2 hours. After confirmation of contralateral hemiparesis, the rats were reanesthetized, injected with MIA or carrier, and the suture withdrawn. Standard physiological parameters were monitored in all groups. Animals were killed the following day. Coronally sliced sections were stained in 1% tetrazolium red. Infarct volume was calculated as a percentage of the contralateral hemisphere volume to eliminate the effect of ipsilateral edema. Infarct volume for controls was 44.2 ± 6.4% (mean ± standard error of mean), for MIA group was 53.5 ± 7.5% (Bonferroni-Dunn, p = 0.31), and for hypothermia group was significantly lower at 6.9 ± 4.7% (p = 0.003). Average temperature at onset of ischemia for MIA and control groups was 37.4°C but for hypothermia group it was 31.4°. In addition, the hypothermic group differed physiologically from the other groups by a lower pH secondary to hypoventilation and hypercarbia. We conclude that MIA as administered here is not protective in temporary cerebral ischemia. Hypothermia, however, is confirmed to be an effective protectant in this model.

UR - http://www.scopus.com/inward/record.url?scp=33748258894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748258894&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748258894

VL - 88

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 1

ER -